Poly(ω-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery
Source abstract
Abstract
In this study, we show that degradable particles of a hydrophobic polymer can effectively deliver drugs to tumors after i.v. administration. Free-standing nanoparticles with diameters of 100-300 nm were successfully fabricated from highly hydrophobic, biodegradable poly(omega-pentadecalactone-co-butylene-co-succinate) (PPBS) copolyesters. PPBS copolymers with various compositions (20-80 mol% PDL unit contents) were synthesized via copolymerization of omega-pentadecalactone (PDL), diethyl succinate (DES), and 1,4-butanediol (BD) using Candida antarctica lipase B (CALB) as the catalyst. Camptothecin (CPT, 12-22%) was loaded into PPBS nanoparticles with high encapsulation efficiency (up to 96%) using a modified oil-in-water single emulsion technique. The CPT-loaded nanoparticles had a zeta potential of about -10 mV. PPBS particles were non-toxic in cell culture. Upon encapsulation, the active lactone form of CPT was remarkably stabilized and no lactone-to-carboxylate structural conversion was observed for CPT-loaded PPBS nanoparticles incubated in both phosphate-buffered saline (PBS, pH=7.4) and DMEM medium for at least 24 h. In PBS at 37 degrees C, CPT-loaded PPBS nanoparticles showed a low burst CPT release (20-30%) within the first 24 h followed by a sustained, essentially complete, release of the remaining drug over the subsequent 40 days. Compared to free CPT, CPT-loaded PPBS nanoparticles showed a significant enhancement of cellular uptake, higher cytotoxicity against Lewis lung carcinoma and 9L cell lines in vitro, a longer circulation time, and substantially better antitumor efficacy in vivo. These results demonstrate the potential of PPBS nanoparticles as long-term stable and effective drug delivery systems in cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Pneumocystis jirovecii pneumonia detection and treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Nanoparticles of biodegradable polymers for new-concept chemotherapy10.1586/17434440.1.1.115 ↗
2. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
3. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy10.1016/j.jconrel.2008.01.013 ↗
4. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting10.1016/S0065-2571(00)00013-3 ↗
5. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect10.1016/j.ejpb.2008.11.010 ↗
6. Plant antitumor agents. I. Isolation and structure of camptothecin a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata10.1021/ja00968a057 ↗
7. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogs10.1002/jps.2600810718 ↗
8. Differential interactions of camptothecin lactone and carboxylate forms with human blood components10.1021/bi00200a013 ↗
9. Camptothecin delivery methods10.1023/A:1020427227285 ↗
10. Topoisomerase-I inhibitors – topotecan and irenotecan10.1016/0305-7372(94)90011-6 ↗
11. The camptothecins10.1016/S0140-6736(03)13780-4 ↗
12. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin10.1016/j.jconrel.2008.02.005 ↗
13. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions
14. Cationic lipid complexed camptothecin (EndoTAG((R))-2) improves antitumoral efficacy by tumor vascular targeting10.4161/cbt.6.6.4207 ↗
15. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles10.1016/j.jconrel.2006.03.012 ↗
16. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability10.1016/j.ijpharm.2005.10.030 ↗
17. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors10.1163/156856207782177918 ↗
18. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker10.1007/s002800050837 ↗
19. In vitro cytotoxicity and in vivo distribution after direct delivery of PEG–camptothecin conjugates to the rat brain10.1021/bc034180o ↗
20. Poly(d,l-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin10.1016/S0168-3659(99)00122-4 ↗
21. Evaluation of antimetastatic activity and systemic toxicity of camptothecin-loaded microspheres in mice injected with B16-F10 melanoma cells
22. Biodegradable nanoparticles for cytosolic delivery of therapeutics10.1016/j.addr.2007.06.003 ↗
23. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles10.1021/mp034002c ↗
24. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors10.1023/A:1007591721877 ↗
25. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain10.1016/S0168-3659(99)00007-3 ↗
26. Improved dissolution and cytotoxicity of camptothecin incorporated into oxidized-cellulose microspheres prepared by spray drying10.1081/PDT-100002254 ↗
27. Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells10.1021/bc800057g ↗
28. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG–PPG–PEG) nanoparticles10.1080/10717540701827154 ↗
29. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin10.1016/j.nano.2009.02.002 ↗
30. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent10.1023/A:1012126301290 ↗
31. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells10.1016/j.biomaterials.2009.01.057 ↗
32. Lipase-catalyzed synthesis of aliphatic polyesters via copolymerization of lactone, dialkyl diester, and diol10.1021/bm800814m ↗
33. Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of carboxylate and lactone forms of 14 new camptothecin derivatives10.1016/S1570-0232(03)00485-9 ↗
34. Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating10.1016/S0378-5173(02)00129-1 ↗
35. Pharmacokinetics and biodistribution of nanoparticles10.1021/mp800049w ↗
36. Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus10.1021/mp8001254 ↗
37. Freeze-drying of nanoparticles: formulation, process and storage considerations10.1016/j.addr.2006.09.017 ↗
38. Stability and freeze-drying of cyclosporine loaded poly(d,l lactide-glycolide) carriers10.1016/S0928-0987(98)00066-9 ↗
39. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(d,l-lactic acid) nanoparticles prepared by an emulsion–diffusion technique10.3109/02652049809006840 ↗
40. Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells10.1023/A:1022219003551 ↗
41. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers10.1023/B:PHAM.0000022411.47059.76 ↗
42. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression10.1023/B:PHAM.0000016250.56402.99 ↗
43. pH-dependent uptake of irinotecan and its active metabolite, SN-38, by intestinal cells10.1002/(SICI)1097-0215(19991112)83:4<491::AID-IJC10>3.0.CO;2-M ↗
44. In vivo cancer targeting and imaging with semiconductor quantum dots10.1038/nbt994 ↗
45. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer–lipid hybrid nanoparticle system10.1124/jpet.106.101154 ↗
46. Determination of camptothecin in biological-fluids using reversed-phase high-performance liquid-chromatography with fluorescence detection10.1016/S0378-4347(00)82339-7 ↗
47. Preparation and antitumor characteristics of PLA/(PEG–PPG–PEG) nanoparticles loaded with camptothecin10.1016/j.ejpb.2007.01.012 ↗